A feasibility randomised trial comparing therapeutic thoracentesis to chest tube insertion for the management of pleural infection: results from the ACTion trialRandomized Controlled Trial Published on 2022-08-302022-10-05 Journal: BMC Pulmonary Medicine [Category] 임상, [키워드] 1:1 Adult patient Adverse average Chest clinician Completeness complex control group COVID-19 pandemic criteria current defined diagnosed eligible Empyema event feasibility group healthcare Hospital stay Hypothesis in both group inclusion criteria Infection insertion International intravenous antibiotics management mean hospital stay Parapneumonic participant Patient patients pleural effusion pleural empyema Primary outcome protocol randomisation randomised Randomised trial readmission recruitment reduce required significantly shorter Standard of care surgical therapeutic Therapies Total treatment allocation Trial were blinded [DOI] 10.1186/s12890-022-02126-4 PMC 바로가기 [Article Type] Randomized Controlled Trial
Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global ContextArticle Published on 2022-08-282022-11-15 Journal: International Journal of Environmental Research an [Category] SARS, 변종, 진단, [키워드] caused cells clinical microbiology clinician consequence Context COVID-19 COVID-19 pandemic diagnostics Effectiveness Factor global health Health Human Vaccines Infection Infectious disease International knowledge mathematical mechanism morbidity and mortality pandemic Pandemics Perspective raise SARS-CoV-2 Scientific community Spread Transmission Travel Treatment vaccination Vaccines Viral variants virus [DOI] 10.3390/ijerph191710712 PMC 바로가기
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant periodArticle Published on 2022-08-252022-11-15 Journal: Frontiers in Immunology [Category] 진단, [키워드] 95%CI absence analyzed Angiotensin-converting enzyme angiotensin-converting enzyme inhibitor angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers ARBs blocker Care CCI Charlson comobidity index clinician Comorbidity Coronavirus disease 2019 COVID-19 COVID-19 patient cut-off value died discharged dominant echocardiographic Endpoint greater help high-risk patient Hospital admission Hospitalization Hospitalized hospitalized COVID-19 patient hospitalized patient in-hospital mortality Infection inhibitor Laboratory laboratory-confirmed males Mortality mortality risk Neutrophil-to-lymphocyte ratio NLR Older omicron Patient physical predict predicted predictor Prevalence prognostic indicator Radiographic receptor reduce risk stratification significantly the primary endpoint therapy [DOI] 10.3389/fimmu.2022.958418 PMC 바로가기
Host Predictors of Broadly Cross-Reactive Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern Differ Between Infection and Vaccination중증 급성 호흡기 증후군 코로나바이러스 2(SARS-CoV-2)에 대한 광범위한 교차 반응성 항체의 숙주 예측 인자는 감염과 예방 접종 사이에 차이가 있습니다.Observational Study Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 임상, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Against antibody Antibody Response B.1.1.7 B.1.351 B.1.617.2 BMI booster Clinical characteristics clinician Clinicians Cohort collected concern contributed coronavirus coronavirus 2 cross-reactive cross-reactive antibodies cross-reactive antibody disease severity enzyme enzyme-linked immunosorbent enzyme-linked immunosorbent assay Factor Health healthy highest Host identify IgG IgG antibodies IgG antibody IgG level immunization Immunocompromised Immunoglobulin Immunoglobulin G individual Infection information metabolic health mounted mRNA vaccination P.1 participant plasma sample plasma samples Population populations predict prospective observational cohort Protective Protective antibody RBD Receptor binding domain Regression model regression models researchers respiratory responses SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus Spike receptor binding domain tested These data vaccination Vaccine Variability variants variants of concern Viral Viral variants virus variants Wuhan younger people [DOI] 10.1093/cid/ciab996 PMC 바로가기 [Article Type] Observational Study
Facilitating Safe Discharge Through Predicting Disease Progression in Moderate Coronavirus Disease 2019 (COVID-19): A Prospective Cohort Study to Develop and Validate a Clinical Prediction Model in Resource-Limited SettingsClinical Trial Published on 2022-08-242022-10-04 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, [키워드] acute respiratory syndrome age biochemical Biomarker C-reactive protein clinical clinical parameter clinical utility clinician Cohort coronavirus coronavirus disease COVID-19 D-dimer death defined demonstrated develop evaluated expressed external validation Facilitating greater health system help hospital identify IL-6 India infections laboratory-confirmed LMIC low- and middle-income country management Model moderate Neutrophil-to-lymphocyte ratio NLR participant Patient patients with moderate prediction presenting Primary outcome procalcitonin prognostic prognostic model progression Prospective provided Rapid test receptor recruited resources respiratory rate SARS-CoV-2 setting Sex soluble Triggering Receptor SpO2 SpO2/FiO2 suPAR supplemental oxygen Symptom Triage utility Vaccines validation cohort [DOI] 10.1093/cid/ciac224 PMC 바로가기 [Article Type] Clinical Trial
Psychological impacts of COVID-19 pandemic in cancer patients on active treatmentResearch article Published on 2022-08-182022-10-05 Journal: Heliyon [Category] 진단, 치료법, [키워드] addition age Analysis Anxiety applied Cancer cancer patient Characteristics Chemotherapy clinician correlation COVID-19 COVID-19 infection COVID-19 pandemic DASS-21 Depression depressive determine develop diagnosed died disorder Effect evaluated high risk IES-R IES-R scores Impact Intervention investigated Mental pandemic Patient predict Psychiatric Psychological psychological condition Psychological distress psychological Impact Psychological intervention psychologically PTSD receive recognize recommendations Result risk serious complication severe complications Stress stress level supportive care Symptoms Treatment [DOI] 10.1016/j.heliyon.2022.e10142 [Article Type] Research article
SARS-CoV-2 antibody progression and neutralizing potential in mild symptomatic COVID-19 patients – a comparative long term post-infection studyArticle Published on 2022-08-172022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] acute infections addition Antibody titer block CLIA clinician Cohort comparability comparable convalescent COVID-19 disease COVID-19 patient Cutoff diagnostics ELISA FIVE help immune immune response increasingly individual immune response Infection information Laboratory long-COVID long-term assay comparison Mild mild progression COVID-19 mild SARS-CoV-2 infection Molecular diagnosis neutralization Neutralizing neutralizing potential Occurrence offered pandemic participant Participants Patient Post-infection progression quantification quantification immune response. Rapid SARS-CoV-2 SARS-CoV-2 antibody serological serological test specific antigen Support Symptom symptomatic vaccination Vaccine WHO [DOI] 10.3389/fimmu.2022.915338 PMC 바로가기
A Rapid and Sensitive Microfluidics-Based Tool for Seroprevalence Immunity Assessment of COVID-19 and Vaccination-Induced Humoral Antibody Response at the Point of Care현장 진료에서 COVID-19 및 예방 접종 유도 체액 항체 반응의 혈청유병 면역 평가를 위한 신속하고 민감한 미세유체 기반 도구Article Published on 2022-08-102022-09-11 Journal: Biosensors [Category] SARS, 변종, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody approved assessment booster causative agent circulating clinical decision clinical decision support tool clinician conditions convalescent plasma COVID-19 cross-reactive antibody death diagnostic diagnostics disease severity donors ecosystem Health help Hospitalization humoral Humoral immunity immunization immunized immunocompromised individual individuals induce infected individual Infection Microfluidics multiple dose multiple doses optimization Patient platform POC POC test Point point of care point-of-care predict proof proof of concept protein-based vaccine Protein-based vaccines Quantitative Rapid reducing researcher response risk robust SARS-CoV-2 SARS-CoV-2 spike SARS-CoV-2-specific IgG sensitive Seroconversion Serological assay Seroprevalence Support the disease the timing vaccination Viral viral variant while [DOI] 10.3390/bios12080621 PMC 바로가기 [Article Type] Article
Atorvastatin for reduction of 28-day mortality in hospitalized COVID-19 patients: study protocol for a randomized, double-blinded, placebo-controlled, clinical trial입원한 COVID-19 환자의 28일 사망률 감소를 위한 아토르바스타틴: 무작위, 이중 맹검, 위약 대조, 임상 시험을 위한 연구 프로토콜Article Published on 2022-08-082022-09-11 Journal: Trials [Category] SARS, 임상, [키워드] 28-day mortality 95% confidence interval Acute kidney injury added adjusted odds ratio All participants all-cause mortality anti-inflammatory drug approval assigned atorvastatin being clinical Clinical improvement clinical trial clinician Consequences Consistency coronavirus COVID-19 COVID-19 patient Delta disease double-blinded drug events healthcare worker Hmg coa hospital hospitalized COVID-19 hospitalized patients In-hospital in-hospital mortality Informed consent institutional review board intensive care isolation hospital logistic regression model mass vaccination mechanical ventilation Mortality neurological once daily P-value pandemic pandemic era participant Patient performed Placebo placebo-controlled Primary outcome protocol Psychological Randomized randomized clinical trial Randomized controlled trial receive recruited reduce mortality reduced reduction Registered registry Research SARS-CoV-2 Sepsis severity severity of COVID-19 standard treatment statins Study protocol supported Tablet the patient university vaccination [DOI] 10.1186/s13063-022-06619-9 PMC 바로가기 [Article Type] Article
Fast and noninvasive electronic nose for sniffing out COVID-19 based on exhaled breath-print recognition Research Published on 2022-08-012022-10-05 Journal: NPJ Digital Medicine [Category] 바이오마커, 변종, 임상, 진단, 치료기술, 치료법, [키워드] Accuracy acute respiratory syndrome approach breath Chest computed tomography Clinical sign clinician Combination composed coronavirus coronavirus disease COVID-19 COVID-19 patients datasets detect diagnose evaluated hospital identify Indonesia Laboratory Linear Discriminant Analysis machine learning algorithm machine learning models multivariable noninvasive polymerase chain positive Region RT-qPCR SARS-CoV-2 sensitivity specificity Support Symptoms [DOI] 10.1038/s41746-022-00661-2 [Article Type] Research